C07D 471/08
Bridged systems
C07D471/08 (Bridged systems) appears on 1,730 US grants and 2,199 published applications in this corpus.
Search patents in C07D- Granted patents
- 1,730
- Published applications
- 2,199
- Assignees
- 807
- Inventors
- 6,471
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 6 | 0 |
| 1977 | 1 | 0 |
| 1978 | 3 | 0 |
| 1979 | 2 | 0 |
| 1980 | 5 | 0 |
| 1981 | 2 | 0 |
| 1982 | 3 | 0 |
| 1983 | 0 | 0 |
| 1984 | 3 | 0 |
| 1985 | 4 | 0 |
| 1986 | 8 | 0 |
| 1987 | 3 | 0 |
| 1988 | 8 | 0 |
| 1989 | 10 | 0 |
| 1990 | 21 | 0 |
| 1991 | 13 | 0 |
| 1992 | 18 | 0 |
| 1993 | 21 | 0 |
| 1994 | 17 | 0 |
| 1995 | 12 | 0 |
| 1996 | 17 | 0 |
| 1997 | 20 | 0 |
| 1998 | 15 | 0 |
| 1999 | 14 | 0 |
| 2000 | 20 | 0 |
| 2001 | 14 | 0 |
| 2002 | 12 | 37 |
| 2003 | 32 | 37 |
| 2004 | 14 | 51 |
| 2005 | 34 | 55 |
| 2006 | 23 | 44 |
| 2007 | 30 | 52 |
| 2008 | 30 | 50 |
| 2009 | 26 | 58 |
| 2010 | 32 | 75 |
| 2011 | 36 | 75 |
| 2012 | 56 | 65 |
| 2013 | 66 | 85 |
| 2014 | 80 | 117 |
| 2015 | 115 | 122 |
| 2016 | 83 | 114 |
| 2017 | 104 | 105 |
| 2018 | 87 | 101 |
| 2019 | 94 | 101 |
| 2020 | 78 | 118 |
| 2021 | 89 | 116 |
| 2022 | 66 | 109 |
| 2023 | 63 | 166 |
| 2024 | 82 | 128 |
| 2025 | 79 | 137 |
| 2026 | 59 | 81 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Compounds for treatment of excitotoxicity29 Sep 2026US 12,747,238 B2Nyrada Pty Ltd
- Method for preparing morphinan derivative having diaryl ether skeleton using novel copper catalyst1 Sep 2026US 12,723,043 B2Nippon Chemiphar Co., Ltd.
- Calixarene compounds and uses thereof25 Aug 2026US 12,714,682 B2Universität Wien
- Bicyclic compound and use thereof25 Aug 2026US 12,715,866 B2SK Biopharmaceuticals Co., Ltd.
- Salt forms of sabcomeline18 Aug 2026US 12,709,611 B2Syremis Therapeutics, Ltd.
- Oxazole trpml1 agonists and uses thereof1 Oct 2026US 2026/0297104 A1Libra Therapeutics, Inc.
- Compounds and methods for modulating splicing24 Sep 2026US 2026/0285853 A1Remix Therapeutics Inc.
- Sik2 modulators and uses thereof17 Sep 2026US 2026/0274820 A1Nimbus Salacia, Inc.
- Sulfamide derivatives as cyclin-dependent kinase 2 inhibitors17 Sep 2026US 2026/0274833 A1Nikang Therapeutics, Inc.
- Compounds and pharmaceutical compositions that degrade swi/snf-related matrix-associated actin-dependent regulator of chromatin subfamily a10 Sep 2026US 2026/0265238 A1Plexium, Inc.
Most cited
By later US patents
- Morphinan compounds151US 7,973,049 B2Concert Pharmaceuticals, Inc. · 2011
- Sigma receptor ligands and the use thereof150US 6,057,371 AVirginia Commonwealth University · 2000
- Morphinan compounds142US 8,188,110 B2Concert Pharmaceuticals, Inc. · 2012
- Morphinan compounds140US 8,541,436 B2Concert Pharmaceuticals, Inc. · 2013
- Urea derivatives and their use as ACAT inhibitors134US 5,621,010 ANisshin Flour Milling Co., Ltd. · 1997